[
  {
    "ts": "2026-01-13T12:48:28+00:00",
    "headline": "Tempus AI (TEM) Soars 15% on $1.1-Billion Deal",
    "summary": "We recently published 10 Stocks With Crazy Gains. Tempus AI Inc. (NASDAQ:TEM) was one of the top performers on Monday. Tempus AI snapped a two-day losing streak on Monday, soaring by as much as 15 percent to $76.33 apiece, as investors took heart from a strong demand for its services, having bagged $1.1 billion in […]",
    "url": "https://finance.yahoo.com/news/tempus-ai-tem-soars-15-124828137.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8cd6eab2-2b32-3342-b8c7-afc388628b1c",
      "content": {
        "id": "8cd6eab2-2b32-3342-b8c7-afc388628b1c",
        "contentType": "STORY",
        "title": "Tempus AI (TEM) Soars 15% on $1.1-Billion Deal",
        "description": "",
        "summary": "We recently published 10 Stocks With Crazy Gains. Tempus AI Inc. (NASDAQ:TEM) was one of the top performers on Monday. Tempus AI snapped a two-day losing streak on Monday, soaring by as much as 15 percent to $76.33 apiece, as investors took heart from a strong demand for its services, having bagged $1.1 billion in […]",
        "pubDate": "2026-01-13T12:48:28Z",
        "displayTime": "2026-01-13T12:48:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4edc292b1dcbd797c07f522ebf66f3cd",
          "originalWidth": 768,
          "originalHeight": 512,
          "caption": "Tempus AI (TEM) Soars 15% on $1.1-Billion Deal",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wpXHllSshAhvRjKQLWZ8dQ--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4edc292b1dcbd797c07f522ebf66f3cd.cf.webp",
              "width": 768,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V0NnFlegXm2HaeSZe_vD3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4edc292b1dcbd797c07f522ebf66f3cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-tem-soars-15-124828137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-tem-soars-15-124828137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "TEM"
            },
            {
              "symbol": "DSKYF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "WHWK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T11:34:04+00:00",
    "headline": "JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff",
    "summary": "BMS looks forward to pivotal readouts for six assets in 2026, ensuring profits after patent expiries for Opdivo and Eliquis.",
    "url": "https://www.pharmaceutical-technology.com/news/jpm26-bms-places-confidence-in-core-pipeline-to-weather-2030-patent-cliff/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "f34e897a-0bab-3418-a5eb-6ae202694225",
      "content": {
        "id": "f34e897a-0bab-3418-a5eb-6ae202694225",
        "contentType": "STORY",
        "title": "JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff",
        "description": "",
        "summary": "BMS looks forward to pivotal readouts for six assets in 2026, ensuring profits after patent expiries for Opdivo and Eliquis.",
        "pubDate": "2026-01-13T11:34:04Z",
        "displayTime": "2026-01-13T11:34:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/1befb27fea6f0219e2f9a175377248ed",
          "originalWidth": 1440,
          "originalHeight": 879,
          "caption": "BMS CEO Christopher Boerner said the company is confident relying on pipeline assets to cover revenues to be lost with patent expiries for Opdivo and Eiquis. Credit: PixelBliss/Shutterstock.com",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fELicu0fO2oppr1xCipxfA--~B/aD04Nzk7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/1befb27fea6f0219e2f9a175377248ed.cf.webp",
              "width": 1440,
              "height": 879,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pi.y3PQlggL_2w3xe2o5KA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/1befb27fea6f0219e2f9a175377248ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/jpm26-bms-places-confidence-in-core-pipeline-to-weather-2030-patent-cliff/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-bms-places-confidence-core-113404682.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T12:58:00+00:00",
    "headline": "Oramed and Lifeward Announce Strategic Transaction",
    "summary": "Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (\"Oramed\") and Lifeward Ltd. (NASDAQ: LFWD) (\"Lifeward\") today announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited investor. The transaction includes the transfer to Lifeward of Oramed's proprietary Protein Oral Drug POD™ delivery technology and Oramed obtaining 49.9% beneficial ownership interest in Lifeward upon the satisfaction of certain terms and conditions. In addit",
    "url": "https://finance.yahoo.com/news/oramed-lifeward-announce-strategic-transaction-125800734.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "3e1281b6-6f41-33c2-a04c-f0d5c4a3f5ed",
      "content": {
        "id": "3e1281b6-6f41-33c2-a04c-f0d5c4a3f5ed",
        "contentType": "STORY",
        "title": "Oramed and Lifeward Announce Strategic Transaction",
        "description": "",
        "summary": "Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (\"Oramed\") and Lifeward Ltd. (NASDAQ: LFWD) (\"Lifeward\") today announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited investor. The transaction includes the transfer to Lifeward of Oramed's proprietary Protein Oral Drug POD™ delivery technology and Oramed obtaining 49.9% beneficial ownership interest in Lifeward upon the satisfaction of certain terms and conditions. In addit",
        "pubDate": "2026-01-13T12:58:00Z",
        "displayTime": "2026-01-13T12:58:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/2a05b36fe8febaad979a185767d450a9",
          "originalWidth": 400,
          "originalHeight": 231,
          "caption": "Oramed_Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rspnu5jGhtH2kiDiZOiSzQ--~B/aD0yMzE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2a05b36fe8febaad979a185767d450a9.cf.webp",
              "width": 400,
              "height": 231,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ijKAR4HpOD4Oe3txweLjSA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2a05b36fe8febaad979a185767d450a9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/oramed-lifeward-announce-strategic-transaction-125800734.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/oramed-lifeward-announce-strategic-transaction-125800734.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LFWD"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ORMP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T14:00:03+00:00",
    "headline": "Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock",
    "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/know-beyond-why-bristol-myers-140003634.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1b9ab221-be83-3870-bfc8-d7a9f05156e8",
      "content": {
        "id": "1b9ab221-be83-3870-bfc8-d7a9f05156e8",
        "contentType": "STORY",
        "title": "Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2026-01-13T14:00:03Z",
        "displayTime": "2026-01-13T14:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5VYVrk.dAWOtAbYePjBVnw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bx6KQdkgJ6y2nL6XqljE4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/know-beyond-why-bristol-myers-140003634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/know-beyond-why-bristol-myers-140003634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T17:35:00+00:00",
    "headline": "ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon",
    "summary": "AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal, cutting U.S. prices while expanding its oncology pipeline.",
    "url": "https://finance.yahoo.com/news/abbv-inks-drug-pricing-deal-173500494.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9ba6192f-ca44-3a47-ba46-c14e9aaa3c18",
      "content": {
        "id": "9ba6192f-ca44-3a47-ba46-c14e9aaa3c18",
        "contentType": "STORY",
        "title": "ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon",
        "description": "",
        "summary": "AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal, cutting U.S. prices while expanding its oncology pipeline.",
        "pubDate": "2026-01-13T17:35:00Z",
        "displayTime": "2026-01-13T17:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbv-inks-drug-pricing-deal-173500494.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbv-inks-drug-pricing-deal-173500494.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]